Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongqiao Biyan Granules for children with asthma and allergic rhinitis
ChiCTR2200066685Phase 4Not yet recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Tongqiao Biyan Granules in allergic rhinitis (AR) and asthma (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Asthma symptom score and Total score of nasal symptoms. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
Tongqiao Biyan Granules
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on ChiCTR2200066685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066685.